MedRxiv

Online repository for preprints in the medical sciences

MedRxiv homepage logo

MedRxiv (pronounced "med-archive") is a free online archive and distribution service for complete but unpublished manuscripts (preprints) in the field of medical, clinical, and health sciences. It is operated by Cold Spring Harbor Laboratory, a not-for-profit research and educational institution, in collaboration with Yale University and the medical publisher BMJ.

History

MedRxiv was launched in June 2019 as a platform to facilitate the dissemination of research findings in the medical sciences before they undergo peer review. The service was inspired by the success of arXiv, a preprint server for physics and other scientific disciplines, and bioRxiv, a preprint server for biology.

The launch of MedRxiv was motivated by the need for a rapid dissemination of research findings, especially in the context of public health emergencies where timely access to information can be critical. The platform gained significant attention during the COVID-19 pandemic, as researchers worldwide sought to share their findings quickly to inform public health responses.

Submission and Screening Process

Authors can submit their manuscripts to MedRxiv, where they undergo a basic screening process to ensure that the content is appropriate for the platform and does not contain any harmful or misleading information. This screening is not a substitute for peer review, and authors are encouraged to submit their work to peer-reviewed journals after posting on MedRxiv.

The screening process includes checks for plagiarism, compliance with ethical standards, and adherence to the platform's policies. Manuscripts that pass the screening are made publicly available on the MedRxiv website, where they can be accessed by researchers, clinicians, and the general public.

Impact and Usage

MedRxiv has become an important resource for the medical research community, providing a venue for the rapid dissemination of new findings. It allows researchers to share their work with the community and receive feedback before formal publication. The platform has also facilitated collaboration and discussion among researchers, accelerating the pace of scientific discovery.

During the COVID-19 pandemic, MedRxiv played a crucial role in the dissemination of research related to the virus, treatments, and vaccines. The platform's open-access model ensured that critical information was available to researchers and policymakers worldwide.

Criticism and Challenges

While MedRxiv has been praised for its role in accelerating the dissemination of research, it has also faced criticism. Some concerns have been raised about the potential for the spread of misinformation, as preprints are not peer-reviewed. MedRxiv addresses these concerns by clearly labeling preprints as unreviewed and by implementing a screening process to filter out inappropriate content.

Related pages

• arXiv
• bioRxiv
• Preprint
• Open access
• Peer review